Cheyne Capital Management (UK)’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,000
Closed -$290K 49
2022
Q4
$290K Buy
+15,000
New +$290K 0.51% 48